| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/05/2005 | US20050095671 Nucleotide sequences coding splice variant of ubiquination regulatory protein for use in prevention and treatment of neurodegenerative disorders |
| 05/05/2005 | US20050095670 Low-substrate-specific racemase for use in producing racemates of various amino acids |
| 05/05/2005 | US20050095669 Eubacterial rna-polymerase mutants with altered product production |
| 05/05/2005 | US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
| 05/05/2005 | US20050095651 Via intein fragments; solid phase synthesis; immobilization; photolithography |
| 05/05/2005 | US20050095650 screening for an agent that modulates capsaicin receptor function |
| 05/05/2005 | US20050095641 Methods and materials for detecting genetic material |
| 05/05/2005 | US20050095640 Intergenic or intronic regions for use as calibration tools in gene expression analysis |
| 05/05/2005 | US20050095638 Kit comprised peptide nucleic acid array for identifying sequences associated with preferential receptor/ligand binding |
| 05/05/2005 | US20050095633 Novel regulators of fungal gene expression |
| 05/05/2005 | US20050095626 Method for separation and purification method of nucleic acid |
| 05/05/2005 | US20050095620 Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 05/05/2005 | US20050095617 Nucleotide sequences coding g protein coupled receptors for use in disease diagnostics and treatment, drug screening, clinical trial monitoring and enhancing cosmetics and/or nutraceutical |
| 05/05/2005 | US20050095615 Methods and compositions for detecting promoter activity and expressing fusion proteins |
| 05/05/2005 | US20050095612 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/05/2005 | US20050095590 Brain expressed cap-2 gene and protein associated with bipolar disorder |
| 05/05/2005 | US20050095587 Molecules for disease detection and treatment |
| 05/05/2005 | US20050095586 Expression vector comprising nucleotide sequences coding homeobox proteins for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095315 Process for the production of alcoholic beverages using maltseed |
| 05/05/2005 | US20050095280 Cationic lipids as delivery vectors for nucleic acids, peptides and other synthetic drugs, in vitro and in vivo; form stable lamellar structures (liposomes) at physiological pH but destabilize to micelles at acidic and alkaline pH |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/05/2005 | US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells |
| 05/05/2005 | US20050095255 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions |
| 05/05/2005 | US20050095254 DNA immunization against Chlamydia infection |
| 05/05/2005 | US20050095253 inducing cancer immune response |
| 05/05/2005 | US20050095252 Promoter for high-throughput screening for inhibitors against Mycobacteria under low carbon conditions |
| 05/05/2005 | US20050095249 Protein markers for lung cancer and use thereof |
| 05/05/2005 | US20050095247 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095240 NaCT as a target for lifespan expansion and weight reduction |
| 05/05/2005 | US20050095231 Transduction; gene therapy; replacing capsid with chimeric molecule containing heterologous trimerization motif and stabilized scFv ligand; host cells |
| 05/05/2005 | US20050095230 For treatment of cancer or virus infection (HIV) |
| 05/05/2005 | US20050095225 Altering epithelial sodium channel (ENaC) activity |
| 05/05/2005 | US20050095199 protecting against parasites and predators; transgenic organisims |
| 05/05/2005 | CA2446460A1 Identification of a novel bovine immunodeficiency-like virus tat protein with enhanced transactivation activity |
| 05/04/2005 | EP1528108A1 Method for producing l-cysteine using bacteria belonging to the genus Escherichia |
| 05/04/2005 | EP1528105A1 A solely pollen-specific promoter |
| 05/04/2005 | EP1528104A1 MEG1 endosperm-specific promoters and genes |
| 05/04/2005 | EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins |
| 05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/04/2005 | EP1528101A1 Immortalized avian cell lines for virus production |
| 05/04/2005 | EP1528067A2 Production and use of normalized DNA libraries |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527341A2 Interfacial biomaterials |
| 05/04/2005 | EP1527340A2 Method for identifying substances |
| 05/04/2005 | EP1527339A2 Method for high throughput cell-based assays using versatile living microarrays |
| 05/04/2005 | EP1527333A1 Fluorescence correlation spectroscopy instrument |
| 05/04/2005 | EP1527200A1 Methods for rolling circle amplification and signal trapping of libraries |
| 05/04/2005 | EP1527197A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof |
| 05/04/2005 | EP1527196A2 Treatment for asthma or allergies |
| 05/04/2005 | EP1527195A2 Method of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5' non-coding region (ncr) of the hcv genome |
| 05/04/2005 | EP1527194A2 Nucleic acid reactions using labels with different redox potentials |
| 05/04/2005 | EP1527189A2 Mutant proteinase inhibitors and uses thereof |
| 05/04/2005 | EP1527188A1 Process for the production of increased amounts of correctly folded heterologous protein in inclusion bodies |
| 05/04/2005 | EP1527185A1 Plastid transformation using modular vectors |
| 05/04/2005 | EP1527184A2 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained |
| 05/04/2005 | EP1527183A2 Novel selection method |
| 05/04/2005 | EP1527182A2 Process for the production of unsaturated fatty acids |
| 05/04/2005 | EP1527181A1 Staphylococcal nuclease fusion proteins for the production of recombinant peptides |
| 05/04/2005 | EP1527180A2 Homogentisate prenyl transferase ("hpt") nucleic acids and polypeptides, and uses thereof |
| 05/04/2005 | EP1527179A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units |
| 05/04/2005 | EP1527176A2 Further novel forms of interfering rna molecules |
| 05/04/2005 | EP1527175A2 Methods and systems for detection and isolation of a nucleotide sequence |
| 05/04/2005 | EP1527174A1 Method for generating molecules with specific properties by recombination and selection |
| 05/04/2005 | EP1527173A1 Gene shuffing by template switching |
| 05/04/2005 | EP1527172A1 Method for nucleic acid extraction and nucleic acid purification |
| 05/04/2005 | EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/04/2005 | EP1527168A1 Saccharose-6-phosphate phosphatase as a target for herbicides |
| 05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 05/04/2005 | EP1527162A1 Method for producing cell lines and organs by means of differentiable cells |
| 05/04/2005 | EP1527160A2 Production of glycosylated macrolides in e. coli |
| 05/04/2005 | EP1527102A1 Proteins and methods useful for assessing risk of cardiovascular disease |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527098A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 05/04/2005 | EP1527095A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli |
| 05/04/2005 | EP1527094A2 T-cell epitopes in erythropoietin |
| 05/04/2005 | EP1527091A1 Corn root preferential promoters and uses thereof |
| 05/04/2005 | EP1527089A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 05/04/2005 | EP1527086A1 Compounds binding to p-selectin |
| 05/04/2005 | EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 05/04/2005 | EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/04/2005 | EP1527080A2 Campylobacter glycans and glycopeptides |
| 05/04/2005 | EP1526868A2 Antibodies |
| 05/04/2005 | EP1526865A2 Compounds for targeting hepatocytes |
| 05/04/2005 | EP1526840A1 Nanoparticles for dna administration to a target organ |
| 05/04/2005 | EP1499747A4 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 05/04/2005 | EP1495135A4 Rapid and specific detection of campylobacter |
| 05/04/2005 | EP1476560A4 Methods for the reduction of stutter in microsatellite amplification |
| 05/04/2005 | EP1465493A4 Cultured and encapsulated pancreatic stem cells |
| 05/04/2005 | EP1442022A4 Polyamide modulators of cox2 transcription |
| 05/04/2005 | EP1364212A4 Three hybrid assay system |
| 05/04/2005 | EP1364035A4 Vectors capable of imparting herbicide resistance and viral cross protection and methods |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP1305628B1 Dielectrically-engineered microparticles |
| 05/04/2005 | EP1276769A4 New neuromedin u receptor nmur2 and nucleotides encoding it |
| 05/04/2005 | EP1261696B1 Rna polymerase mutants with increased thermostability |
| 05/04/2005 | EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression |